戻る Agenda
Session 3: GDPR and Data Transparency Requirements
Session Chair(s)
Merete Joergensen, MBA, MSC
Clinical Disclosure and Transparency Expert
Merete-J Consulting, Denmark
How to ensure Data privacy and being Transparent at the same time gives rise to some considerations and concerns. What does this mean from a patient perspective, what are the considerations from industry trying to manoeuvre the requirements and what are the legal reality when working in this field.
Speaker(s)
David Peloquin, JD
Ropes & Gray LLP, United States
Senior Advisor, MRCT Center; Associate, Health care Group
Patient's perspectives on Data Privacy versus Data Transparency
Deborah Collyar
Patient Advocates In Research (PAIR), United States
President
GDPR and Data Transparency: An Industry Perspective’
Anne Cutting
GSK, United Kingdom
Director, Human Subject Research Governance